O'Day Steven J 4
4 · AGENUS INC · Filed Jun 18, 2024
Insider Transaction Report
Form 4
AGENUS INCAGEN
O'Day Steven J
Chief Medical Officer
Transactions
- Award
Stock Option
2024-06-11+10,000→ 10,000 totalExercise: $12.26Exp: 2034-01-16→ Common Stock (10,000 underlying) - Award
Stock Option
2024-06-11+37,907→ 37,907 totalExercise: $12.26Exp: 2034-01-16→ Common Stock (37,907 underlying)
Footnotes (2)
- [F1]Options were granted on January 16, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. These options vest as to 50% of the underlying shares on June 27, 2024 and 50% of the underlying shares on September 27, 2024. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 758,140 Stock Options with an exercise price of $0.61.
- [F2]Options were granted on January 16, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 16, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 200,000 Stock Options with an exercise price of $0.61.